ImaRx also announced the appointment of Garen Manvelian as Chief Medical Officer. The company has also promoted Jennifer Marshall to Vice President, Corporate Development.
The company said that Manvelian would direct the ongoing Sonolysis microbubble clinical program, as well as oversees medical affairs of the company's commercial product, Abbokinase. Marshall, will be responsible for overseeing and guiding the strategic direction for corporate development activities within ImaRx.
For comments and feedback: contact editorial@rttnews.com Copyright(c) 2007 RealTimeTraders.com, Inc. All Rights Reserved
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
|
|
